You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
McKesson
Johnson and Johnson
AstraZeneca
Baxter
Harvard Business School

Last Updated: September 30, 2020

DrugPatentWatch Database Preview

Litigation Details for Spectrum Pharmaceuticals Inc v. InnoPharma Inc. (D. Del. 2012)

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Small Molecule Drugs cited in Spectrum Pharmaceuticals Inc v. InnoPharma Inc.
The small molecule drug covered by the patent cited in this case is   Start Trial .

Details for Spectrum Pharmaceuticals Inc v. InnoPharma Inc. (D. Del. 2012)

Date Filed Document No. Description Snippet Link To Document
2012-03-02 1 expiration of United States Patent No. 6,500,829 ("the '829 patent"), which covers Fusilev…Trademark Office issued U.S. Patent No. 6,500,829, entitled "Substantially Pure Diastereoisomers… COUNT FOR INFRINGEMENT OF U.S. PATENT NO. 6,500,829 20. Plaintiffs reallege… I. This is an action for patent infringement under the patent laws of the United States, 35 U.S.C… THE PATENT-IN-SUIT 9. On December 31, 2002, the United States Patent and Trademark External link to document
2014-10-17 196 of Invalidity of Claims 1 and 2 of U.S. Patent No. 6,500,829 - filed by Mylan Institutional Inc., Mylan… 4 August 2015 1:12-cv-00260-RGA-CJB Patent None District Court, D. Delaware External link to document
2014-10-17 198 of Invalidity of Claims 1 and 2 of U.S. Patent No. 6,500,829, filed by Mylan Institutional Inc., Mylan… 4 August 2015 1:12-cv-00260-RGA-CJB Patent None District Court, D. Delaware External link to document
2014-10-17 199 Noninfringement of Claims 5 through 14 of U.S. Patent No. 6,500,829, filed by Mylan Institutional Inc., Mylan… 4 August 2015 1:12-cv-00260-RGA-CJB Patent None District Court, D. Delaware External link to document
2014-10-17 201 of Invalidity of Claims 1 and 2 of U.S. Patent No. 6,500,829, by Mylan Institutional Inc., Mylan Institutional… 4 August 2015 1:12-cv-00260-RGA-CJB Patent None District Court, D. Delaware External link to document
2014-11-18 224 of Invalidity of Claims 1 and 2 of U.S. Patent No. 6,500,829 filed by Spectrum Pharmaceuticals Inc, … 4 August 2015 1:12-cv-00260-RGA-CJB Patent None District Court, D. Delaware External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Boehringer Ingelheim
Moodys
Express Scripts
Colorcon
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.